244 related articles for article (PubMed ID: 23110108)
21. Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway.
Yi M; Dou F; Lu Q; Yu Z; Chen H
Neurosci Lett; 2016 Jun; 624():62-71. PubMed ID: 27163196
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of KCa3.1 by depolarisation and 2-aminoethoxydiphenyl borate (2-APB) during Ca²⁺ release activated Ca²⁺ (CRAC) entry in human erythroleukemia (HEL) cells: Implications for the interpretation of 2-APB inhibition of CRAC entry.
Littlechild R; Zaidman N; Khodaverdi D; Mason MJ
Cell Calcium; 2015 Feb; 57(2):76-88. PubMed ID: 25601026
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
Li H; Zhao JL; Zhang YM; Han SX
Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
[TBL] [Abstract][Full Text] [Related]
24. Histone Deacetylases Enhance Ca
Matsui M; Terasawa K; Kajikuri J; Kito H; Endo K; Jaikhan P; Suzuki T; Ohya S
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262728
[TBL] [Abstract][Full Text] [Related]
25. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
[TBL] [Abstract][Full Text] [Related]
26. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
Koshy S; Wu D; Hu X; Tajhya RB; Huq R; Khan FS; Pennington MW; Wulff H; Yotnda P; Beeton C
PLoS One; 2013; 8(10):e76740. PubMed ID: 24146918
[TBL] [Abstract][Full Text] [Related]
27. KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.
Grimaldi A; D'Alessandro G; Golia MT; Grössinger EM; Di Angelantonio S; Ragozzino D; Santoro A; Esposito V; Wulff H; Catalano M; Limatola C
Cell Death Dis; 2016 Apr; 7(4):e2174. PubMed ID: 27054329
[TBL] [Abstract][Full Text] [Related]
28. Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors.
D'Alessandro G; Limatola C; Catalano M
Curr Neuropharmacol; 2018; 16(5):636-643. PubMed ID: 28707595
[TBL] [Abstract][Full Text] [Related]
29. Serum-activated K and Cl currents underlay U87-MG glioblastoma cell migration.
Catacuzzeno L; Aiello F; Fioretti B; Sforna L; Castigli E; Ruggieri P; Tata AM; Calogero A; Franciolini F
J Cell Physiol; 2011 Jul; 226(7):1926-33. PubMed ID: 21506123
[TBL] [Abstract][Full Text] [Related]
30. Calcium-activated potassium channel KCa3.1 in lung dendritic cell migration.
Shao Z; Makinde TO; Agrawal DK
Am J Respir Cell Mol Biol; 2011 Nov; 45(5):962-8. PubMed ID: 21493782
[TBL] [Abstract][Full Text] [Related]
31. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
[TBL] [Abstract][Full Text] [Related]
32. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel.
Huang C; Pollock CA; Chen XM
PLoS One; 2014; 9(4):e95173. PubMed ID: 24733189
[TBL] [Abstract][Full Text] [Related]
33. Evidence of Decreased Activity in Intermediate-Conductance Calcium-Activated Potassium Channels During Retinoic Acid-Induced Differentiation in Motor Neuron-Like NSC-34 Cells.
Chen PC; Ruan JS; Wu SN
Cell Physiol Biochem; 2018; 48(6):2374-2388. PubMed ID: 30114691
[TBL] [Abstract][Full Text] [Related]
34. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
36. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
37. Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.
Chen YJ; Wallace BK; Yuen N; Jenkins DP; Wulff H; O'Donnell ME
Stroke; 2015 Jan; 46(1):237-44. PubMed ID: 25477223
[TBL] [Abstract][Full Text] [Related]
38. Arecoline inhibits intermediate-conductance calcium-activated potassium channels in human glioblastoma cell lines.
So EC; Huang YM; Hsing CH; Liao YK; Wu SN
Eur J Pharmacol; 2015 Jul; 758():177-87. PubMed ID: 25843414
[TBL] [Abstract][Full Text] [Related]
39. Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients.
Friebel K; Schönherr R; Kinne RW; Kunisch E
J Cell Physiol; 2015 Jul; 230(7):1677-88. PubMed ID: 25545021
[TBL] [Abstract][Full Text] [Related]
40. Altered K
Seo CH; Cui HS; Kim JB
Transl Res; 2021 Oct; 236():133-146. PubMed ID: 33905948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]